Control of Cell Proliferation by Runx Proteins
Runx 蛋白对细胞增殖的控制
基本信息
- 批准号:7172238
- 负责人:
- 金额:$ 26.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-02-01 至 2010-01-31
- 项目状态:已结题
- 来源:
- 关键词:Acute Myelocytic LeukemiaAddressAffectAnimalsArthropodsBiochemicalBiologicalBiological ModelsCell CycleCell Cycle RegulationCell Differentiation processCell ProliferationCell physiologyCellsCleidocranial DysplasiaCore FacilityCyclin D1CytometryDNADNA BindingDataDefectDevelopmentDiseaseEmbryoEmbryonic DevelopmentEnvironmentFailureFundingGene Expression RegulationGene ProteinsGene TargetingGenesGenetic TranscriptionGenomeGoalsGrantHalf-LifeHealthHematopoiesisHumanMammalsMass Spectrum AnalysisMediatingMethodsMicroscopyMitoticMolecularMutateMutationNatureNon - mammalian blastulaOncogenesOsteogenesisPatternPhasePhase TransitionProtein BindingProteinsProteolysisPurposeRUNX1 geneRangeReagentRegulator GenesResearchResearch PersonnelRoleSea UrchinsSiteSpinal GangliaStagingStomachStomach CarcinomaStrongylocentrotus purpuratusSystemT-Cell LymphomaTestingTrans-ActivatorsTranscriptional ActivationTranscriptional RegulationUbiquitinationUnited States National Institutes of Healthbaseblastocystbody systemchromatin immunoprecipitationdesignembryo cellexpectationexperiencegenome sequencinginnovationleukemiamalignant stomach neoplasmneurodevelopmentprogramspromoterresearch studyrunx proteinstranscription factor
项目摘要
DESCRIPTION (provided by applicant): Runt domain (Runx) transcription factors are key regulators of animal development. Each of the three mammalian Runx genes is required for the development of a major organ system, and in humans all three are associated with disease caused by uncontrolled cell proliferation. RUNXl is required for definitive hematopoiesis, and is the most frequently mutated gene in human leukemia; RUNX2 is required for osteogenesis, and its haploinsufficiency causes cleidocranial dysplasia; and RUNX3 is required for neural development in the dorsal root ganglia and for control of cell proliferation in the developing stomach, and is frequently deleted or silenced in human stomach cancer. The purpose of this grant is to define the molecular mechanisms through which Runx proteins control cell proliferation during development. Toward this end we are using sea urchin embryogenesis as a simplified model system. Unlike mammals, which have 3 Runx genes, the sea urchin Strongylocentrotus purpuratus has only a single Runx gene (SpRunt). As is the case with other Runx proteins, SpRunt forms a heterodimer with a beta subunit (SpCBFbeta). Our preliminary data show that SpRunt is required for the normal program of cell proliferation during embryogenesis and for the transcriptional activation of cyclin D. The specific aims of this grant are: (1) to further define the roles of SpRunt in cell proliferation; (2) to determine how SpRunt functions within the context of the cyclinD cis-regulatory system; and (3) to investigate how SpRunt activity is developmentally regulated by its heterodimeric partner, SpCBFbeta. These aims will be achieved by exploiting the strengths of the sea urchin embryo as a system for biochemical and molecular analyses of cell physiology, gene regulation, and development, and the availability of the S. purpuratus genome sequence, which will greatly facilitate both the cis-regulatory analysis of genes and the identification of purified proteins by mass spectrometry.
描述(由申请人提供): Runt结构域(Runx)转录因子是动物发育的关键调控因子。哺乳动物的三个Runx基因中的每一个都是主要器官系统发育所必需的,在人类中,这三个基因都与不受控制的细胞增殖引起的疾病有关。RUNX 1是确定性造血所需的,并且是人白血病中最频繁突变的基因; RUNX 2是骨生成所需的,并且其单倍性不足引起锁骨颅骨发育不良; RUNX 3是背根神经节中的神经发育和发育中的胃中的细胞增殖的控制所需的,并且在人胃癌中经常缺失或沉默。这项资助的目的是确定Runx蛋白在发育过程中控制细胞增殖的分子机制。为此,我们使用海胆胚胎发生作为简化的模型系统。与哺乳动物有3个Runx基因不同,海胆只有一个Runx基因(SpRunt)。与其他Runx蛋白一样,SpRunt与β亚基(SpCBFbeta)形成异二聚体。我们的初步数据表明,SpRunt是胚胎发生过程中细胞增殖的正常程序和细胞周期蛋白D的转录激活所必需的。这项资助的具体目的是:(1)进一步确定SpRunt在细胞增殖中的作用;(2)确定SpRunt如何在cyclinD顺式调节系统中发挥作用;(3)研究SpRunt活性如何通过其异源二聚体伴侣SpCBFbeta进行发育调节。这些目标将通过利用海胆胚胎作为细胞生理学、基因调控和发育的生化和分子分析系统的优势以及S.这将极大地促进基因的顺式调控分析和通过质谱法鉴定纯化的蛋白质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES A COFFMAN其他文献
JAMES A COFFMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES A COFFMAN', 18)}}的其他基金
Environmental arsenic, immunoregulation, and viral disease risk
环境砷、免疫调节和病毒性疾病风险
- 批准号:
10589936 - 财政年份:2022
- 资助金额:
$ 26.19万 - 项目类别:
Environmental arsenic, immunoregulation, and viral disease risk
环境砷、免疫调节和病毒性疾病风险
- 批准号:
10452270 - 财政年份:2022
- 资助金额:
$ 26.19万 - 项目类别:
Gene regulatory circuitry underlying the dynamic control of glucocorticoid signaling
糖皮质激素信号传导动态控制的基因调控电路
- 批准号:
9806172 - 财政年份:2019
- 资助金额:
$ 26.19万 - 项目类别:
Gene regulatory circuitry underlying the dynamic control of glucocorticoid signaling
糖皮质激素信号传导动态控制的基因调控电路
- 批准号:
9978850 - 财政年份:2019
- 资助金额:
$ 26.19万 - 项目类别:
ORAL-ABORAL AXIS SPECIFICATION IN THE SEA URCHIN EMBRYO
海胆胚胎的口腔轴规格
- 批准号:
7720077 - 财政年份:2008
- 资助金额:
$ 26.19万 - 项目类别:
Redox-sensitive developmental pathways and gene regulatory networks
氧化还原敏感的发育途径和基因调控网络
- 批准号:
7629068 - 财政年份:2007
- 资助金额:
$ 26.19万 - 项目类别:
Redox-sensitive developmental pathways and gene regulatory networks
氧化还原敏感的发育途径和基因调控网络
- 批准号:
7496998 - 财政年份:2007
- 资助金额:
$ 26.19万 - 项目类别:
ORAL-ABORAL AXIS SPECIFICATION IN THE SEA URCHIN EMBRYO
海胆胚胎的口腔轴规格
- 批准号:
7610081 - 财政年份:2007
- 资助金额:
$ 26.19万 - 项目类别:
Redox-sensitive developmental pathways and gene regulatory networks
氧化还原敏感的发育途径和基因调控网络
- 批准号:
7289928 - 财政年份:2007
- 资助金额:
$ 26.19万 - 项目类别:
Control of Cell Proliferation by Runx Proteins
Runx 蛋白对细胞增殖的控制
- 批准号:
7106846 - 财政年份:2005
- 资助金额:
$ 26.19万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 26.19万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 26.19万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 26.19万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 26.19万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 26.19万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 26.19万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 26.19万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 26.19万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 26.19万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 26.19万 - 项目类别:
Research Grant